Management of prenatally diagnosed lung lesions

Semin Pediatr Surg. 2013 Feb;22(1):24-9. doi: 10.1053/j.sempedsurg.2012.10.005.

Abstract

Prenatal diagnosis provides insight into the in utero evolution of fetal thoracic lesions such as congenital cystic adenomatoid malformation (CCAM), bronchopulmonary sequestration (BPS), or hybrid lesions. Serial sonographic study of fetuses with thoracic lesions has helped define the natural history of these lesions, determine the pathophysiologic features that affect clinical outcome, and formulate in utero and postnatal management based on prognosis.

Publication types

  • Review

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use
  • Betamethasone / therapeutic use
  • Bronchopulmonary Sequestration / diagnostic imaging
  • Bronchopulmonary Sequestration / embryology
  • Bronchopulmonary Sequestration / physiopathology
  • Bronchopulmonary Sequestration / therapy*
  • Cystic Adenomatoid Malformation of Lung, Congenital / diagnostic imaging
  • Cystic Adenomatoid Malformation of Lung, Congenital / embryology
  • Cystic Adenomatoid Malformation of Lung, Congenital / physiopathology
  • Cystic Adenomatoid Malformation of Lung, Congenital / therapy*
  • Female
  • Fetal Therapies / methods*
  • Fetus / embryology
  • Fetus / physiopathology
  • Fetus / surgery
  • Humans
  • Infant, Newborn
  • Perinatal Care
  • Pneumonectomy / methods
  • Postnatal Care
  • Pregnancy
  • Ultrasonography, Prenatal

Substances

  • Anti-Inflammatory Agents
  • Betamethasone